During the interview, I heard NP state that Vyera

During the interview, I heard NP state that Vyera would be responsible for deciding what the price for leronlimab since they are the experts. I know there have to be guidelines when pricing, but that sounds like possible fuel for the bashers. I think it's important for CYDY to show we are in control of this product and not passing the torch when it comes to pricing. Especially with Vyera's history. Just a take away I had from interview.